Lv41
770 积分 2023-03-27 加入
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
22天前
已完结
Engineering CAR-T Cells for Next-Generation Cancer Therapy
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
2个月前
已完结
In vivo site-specific engineering to reprogram T cells
3个月前
已完结
Recent advances in therapeutic cancer vaccines
3个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
3个月前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
3个月前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
3个月前
已完结
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
3个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell-engaging bispecific antibody targeting human claudin 6
3个月前
已关闭
皖公网安备34019202002308
